A multe-center, non-interventional study in Europe to evaluate Pliaglis in daily practice

A multi-center, non-interventional study, including up to 700 subjects at approximately 70 sites in 5 European countries to evaluate the post-market safety profile of Pliaglis and the efficacy of Pliaglis in terms of pain reduction, satisfaction with the product and daily practice use prior to pre-defined aesthetic procedures.

Inclusion Criteria:

• Signed informed consent

• Patient treated with Pliaglis by the Investigator or other healthcare professional according to label (refer to SmPC)

• Patient had already consented to receive any one or more of the following aesthetic procedures after Pliaglis administration:

  1. Pulsed-dye laser therapy
  2. Laser-assisted hair removal
  3. Non-ablative laser resurfacing
  4. Dermal filler injection
  5. Vascular access

Exclusion Criteria:

• Patient treated with other injectable or topical anaesthetic(s) for the pre-defined aesthetic procedure
• Previous participation in this study

Patient aiming to perform one or more of the following aesthetic procedures:

1. Pulsed-dye laser therapy
2. Laser-assisted hair removal
3. Non-ablative laser resurfacing
4. Dermal filler injection
5. Vascular access